Growing number of births linked to Ozempic, a widely used weight loss medication, as it has been identified as potentially reducing the effectiveness of birth control pills.
In recent discussions online, a new term has emerged - "Ozempic babies." This moniker refers to unexpected pregnancies among women who were using these medications for weight loss and diabetes management.
Ozempic, first approved in the European Union in 2018 for diabetes treatment, and Wegovy, introduced later as a weight loss medication, have gained popularity due to their ability to slow down stomach emptying, making consumers feel satiated for longer and eat less. However, this side effect also affects how food and medications are absorbed, leading to unforeseen consequences.
Experts, such as plastic surgeon Jonathan Kaplan in San Francisco, have pointed out that the side effect isn't new or unknown. They advise that individuals using these medications should consider alternative methods of birth control, such as condoms, caps, sponges, spermicides, or copper intrauterine devices, to mitigate the risk.
The drugmakers themselves have advised ceasing the use of these drugs when trying to conceive or being pregnant, as they were not properly tested on pregnant people. Despite this, some individuals are finding humor in the irony of using Ozempic for weight loss and ending up pregnant.
On Twitter, netizens are discussing the idea of losing weight and having a baby simultaneously with these medications. Some are even speculating what an Ozempic-grown baby would look like, with a general sentiment that such a baby would be skinny.
However, it's important to note that there are no current reports or data available to establish whether GLP-1, the category these drugs fall under, is associated with birth defects, miscarriage, or adverse outcomes for either the mother or the baby.
The term "Ozempic baby" is causing concern and is not being taken lightly. It's a reminder for those using these medications to be vigilant about birth control and to consult with their healthcare providers about any potential risks.
Two other popular reads related to this topic include discussions on the implications of these surprise pregnancies on the broader use of these medications and the potential need for further research into the effects of GLP-1 drugs during pregnancy.
